menu
    • menu

    Company profile for Fulcrum Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug ...
    We launched Fulcrum Therapeutics with a bold vision: To change the course of genetically defined diseases by treating them at their root cause. Our approach to drug discovery generates significant insights into disease biology and allows us to think creatively about the best way to modulate and balance gene expression. The result: A patient-focused product engine designed to systematically identify and validate cellular drug targets that can modulate gene expression to treat the known root cause of genetically defined diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Fulcrum TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    26 Landsdowne Street Cambridge, MA 02139
    Telephone
    Telephone
    617-651-8851
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.fulcrumtx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/fulcrum-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/fulcrumtx/

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Fulcrum Therapeutics Reports Positive Phase 1B Pociredir Results
    Fulcrum Therapeutics Reports Positive Phase 1B Pociredir Results

    06 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/06/3201099/0/en/Fulcrum-Therapeutics-Announces-Positive-Initial-Results-from-the-20-mg-Dose-Cohort-of-the-Phase-1b-PIONEER-Trial-of-Pociredir-in-Sickle-Cell-Disease-at-the-67th-American-Society-of.html

    GLOBENEWSWIRE
    06 Dec 2025
    Share Share
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq LR
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq LR

    05 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/05/3200991/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    05 Dec 2025
    Share Share
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq LR
    Fulcrum Therapeutics Discloses Inducement Grants Per Nasdaq LR

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183980/0/en/Fulcrum-Therapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Fulcrum Therapeutics To Unveil Pociredir Data In Sickle Cell
    Fulcrum Therapeutics To Unveil Pociredir Data In Sickle Cell

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179867/0/en/Fulcrum-Therapeutics-to-Present-New-Clinical-Data-from-the-PIONEER-trial-of-Pociredir-in-Sickle-Cell-Disease-at-the-67th-American-Society-of-Hematology-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Fulcrum Pharma Reveals Q3 2025 Business Highlights & Results
    Fulcrum Pharma Reveals Q3 2025 Business Highlights & Results

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176248/0/en/Fulcrum-Therapeutics-Announces-Recent-Business-Highlights-and-Financial-Results-for-Third-Quarter-2025.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Fulcrum Therapeutics To Host Q3 2025 Financial Results
    Fulcrum Therapeutics To Host Q3 2025 Financial Results

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3171135/0/en/Fulcrum-Therapeutics-to-Host-Third-Quarter-2025-Financial-Results-Conference-Call-and-Webcast-on-Wednesday-October-29-2025-at-8-00-a-m-ET.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search